Real Options and Intellectual Property: Capital Budgeting Under Imperfect Patent Protection: 587 (Lecture Notes in Economics and Mathematical Systems, 587) - Image 1

£76.32

This is the most expensive it has ever been. Walk away.

£76 today · previous high £76 · all-time low £63

Springer Real Options and Intellectual Property: Capital Budgeting Under Imperfect Patent Protection: 587 (Lecture Notes in Economics and Mathematical Systems, 587)

Name: Real Options and Intellectual Property: Capital Budgeting Under Imperfect Patent Protection: 587 (Lecture Notes in Economics and Mathematical Systems, 587)
Brand: Springer
Price: 76.32 GBP
Availability: InStock

Econometrics

Price Distribution

Price distribution over 71 days • 3 price levels

Days at Price

Current Price

Price Analysis

Most common price: £63 (54 days, 76.1%)

Price range: £63 - £76

Price levels: 3 different prices over 71 days

Description

Over the last years, due to intensive competition in the knowledge economy, legal aspects surrounding intellectual property (IP) rights - including litigation and settlement - have continuously gained in importance. Correspondingly, professional IP management has become an indispensable element of successful value-based management (VBM) in research-intensive firms. With this text, the author proposes an integrated approach to patent risk and capital budgeting in pharmaceutical research and development (R and D), developing an option-based view (OBV) of imperfect patent protection, which draws upon contingent-claims analysis, stochastic game theory, as well as novel numerical methods. Bridging a widening gap between recent advances in the theory of financial analysis and current challenges faced by pharmaceutical companies, the text re-initiates a discussion about the contribution of quantitative frameworks to value-based R and D management.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 3540482636
Category: Books > Subjects > Business, Finance & Law > Economics > Econometrics
Domain: Amazon UK
Release Date: 10 January 2007
Listed Since: 31 January 2007

Barcode

No barcode data available

This is the most expensive it has ever been. Walk away.

Springer Real Options and Intellectual Property: Capital Budgeting Under Imperfect Patent Protection: 587 (Lecture Notes in Economics and Mathematical Systems, 587)

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Patentwesen und Innovation: Eine wirtschaftliche Analyse der Zusammenhänge am Beispiel der pharmazeutischen Branche

Patent Rights in Pharmaceuticals in Developing Countries: Major Challenges for the Future

Economics of Drug R&D:Financing, Strategic and Policy Considerations; Price Regulation,Capital Market Imperfections and Strategic R&D Investment Behavior in the Pharmaceutical Industry

Pharmaceutical Innovation, Competition and Patent Law: A Trilateral Perspective

Balancing Wealth and Health - Intellectual Property & Medicine Access

Intellectual Property and Health Technologies: Balancing Innovation and the Public's Health

Drugs, Patents and Policy: A Contextual Study of Hong Kong

The International Political Economy of Intellectual Property Rights (New Horizons in Intellectual Property series)

Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health, and Pharmaceuticals (Law, Development and Globalization)

Compulsory Patent Licensing and Access to Medicines: A Silver Bullet Approach to Public Health? (Palgrave Studies in Public Health Policy Research)

Intellectual Property and Health Technologies - Patent Law Guide

Patent Law and Intellectual Property in the Medical Field (Advances in Healthcare Information Systems and Administration)

Evergreening Patent Exclusivity in Pharmaceutical Products: Supplementary Protection Certificates, Orphan Drugs, Paediatric Extensions and ATMPs

Political Economy of Pharmaceutical Patents - WTO Trade Policy

Competition Law and Patents: A Follow-on Innovation Perspective in the Biopharmaceutical Industry (New Horizons in Competition Law and Economics series)

Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries

CRC Press - Intellectual Property Issues in Life Sciences Book

A Politics of Patent Law: Crafting the Participatory Patent Bargain (Routledge Research in Intellectual Property)

Patent Portfolio Deployment: Bridging The R&D, Patent and Product Markets

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Intellectual Property and Access to Medicines in Africa: A Regional Framework for Access (Routledge Research in Intellectual Property)

Intellectual Property Strategies for Start-ups: A Practical Guide (Elgar Practical Guides)

Innovation, Startups and Intellectual Property Management: Strategies and Evidence from Latin America and other Regions

The Thriving Biopharma Business: How to Unlock Value and Drive Success in Biotech and Pharma

This is the most expensive it has ever been. Walk away.

Springer Real Options and Intellectual Property: Capital Budgeting Under Imperfect Patent Protection: 587 (Lecture Notes in Economics and Mathematical Systems, 587)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Patentwesen und Innovation: Eine wirtschaftliche Analyse der Zusammenhänge am Beispiel der pharmazeutischen Branche

Patent Rights in Pharmaceuticals in Developing Countries: Major Challenges for the Future

Economics of Drug R&D:Financing, Strategic and Policy Considerations; Price Regulation,Capital Market Imperfections and Strategic R&D Investment Behavior in the Pharmaceutical Industry

Pharmaceutical Innovation, Competition and Patent Law: A Trilateral Perspective

Balancing Wealth and Health - Intellectual Property & Medicine Access

Intellectual Property and Health Technologies: Balancing Innovation and the Public's Health

Drugs, Patents and Policy: A Contextual Study of Hong Kong

The International Political Economy of Intellectual Property Rights (New Horizons in Intellectual Property series)

Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health, and Pharmaceuticals (Law, Development and Globalization)

Compulsory Patent Licensing and Access to Medicines: A Silver Bullet Approach to Public Health? (Palgrave Studies in Public Health Policy Research)

Intellectual Property and Health Technologies - Patent Law Guide

Patent Law and Intellectual Property in the Medical Field (Advances in Healthcare Information Systems and Administration)

Evergreening Patent Exclusivity in Pharmaceutical Products: Supplementary Protection Certificates, Orphan Drugs, Paediatric Extensions and ATMPs

Political Economy of Pharmaceutical Patents - WTO Trade Policy

Competition Law and Patents: A Follow-on Innovation Perspective in the Biopharmaceutical Industry (New Horizons in Competition Law and Economics series)

Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries

CRC Press - Intellectual Property Issues in Life Sciences Book

A Politics of Patent Law: Crafting the Participatory Patent Bargain (Routledge Research in Intellectual Property)

Patent Portfolio Deployment: Bridging The R&D, Patent and Product Markets

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Intellectual Property and Access to Medicines in Africa: A Regional Framework for Access (Routledge Research in Intellectual Property)

Intellectual Property Strategies for Start-ups: A Practical Guide (Elgar Practical Guides)

Innovation, Startups and Intellectual Property Management: Strategies and Evidence from Latin America and other Regions

The Thriving Biopharma Business: How to Unlock Value and Drive Success in Biotech and Pharma